Improving brain and heart health through a specific diet
Official title: Optimized Tailored Interventions in Metabolic and Lifestyle Outcomes: Examining the Effects of the Mediterranean-DASH Intervention for Neurodegenerative Delay(MIND) on Cognitive Performance, Metabolic Health and Lifestyle Outcomes Using Advanced Machine Learning Strategies
Run by University of Illinois at Urbana-Champaign · NCT06605898 · Data updated 2026-11-12
This study is testing if following the MIND diet can improve brain and heart health in middle-aged adults compared to a standard healthy diet.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 45 Years to 64 Years |
| Sex | All |
| Enrollment | 72 (estimated) |
| Sponsor | University of Illinois at Urbana-Champaign Academic / other |
| Locations | 1 site (Urbana, Illinois) |
| Status | Recruiting |
| Started | July 3, 2024 |
| Main results expected | December 31, 2026 |
| Study ends | December 31, 2027 |
| Registry record updated | September 20, 2024 |
| Trial ID | NCT06605898 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are middle-aged adults aged 45-64 who are cognitively intact and have no significant health issues or dietary restrictions.
✕Probably not a fit
Patients with neurological diseases, significant gastrointestinal issues, or those currently on specific medications may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial aims to determine if adherence to the Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) diet enhances cognitive performance and heart health compared to a standard healthy diet in middle-aged adults. Participants will be divided into three groups: one selected through predictive analytics, one following the MIND diet without pre-selection, and a control group on a standard healthy diet. Over 12 weeks, participants will receive daily meals and smoothies delivered to their homes and will complete various assessments, including memory tests and health evaluations. The study seeks to understand the effectiveness of the MIND diet and the role of predictive analytics in identifying those who may benefit most.
Why it matters
Potential benefit: If successful, this study could lead to improved dietary recommendations that enhance cognitive and cardiovascular health in middle-aged adults.
How similar studies have gone: Other studies have shown promising results with dietary interventions aimed at improving cognitive and heart health, suggesting this approach may be effective.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * 45-64 years of age * 20/20 or corrected vision * No food allergies or intolerances * Not pregnant, lactating, or have given birth in the past 12 months * Do not smoke, use tobacco, or abuse drugs * Absence of liver or gastrointestinal diseases (i.e., primary biliary cirrhosis or gallbladder disease, chronic constipation, diarrhea, Crohn's disease, celiac disease, ulcerative colitis, irritable bowel syndrome, diverticulosis, stomach or duodenal ulcers), hepatitis, HIV, and cancer * Not currently taking oral hypoglycemic agents, or insulin * No history of malabsorptive or bariatric surgery * Cognitively intact with no prior diagnosis of neurological disease (i.e., mild cognitive impairment, Alzheimer's disease, vascular dementia, and/or Asperger's syndrome) * Able to consume the study meals * Not enrolled in another dietary, exercise, or medication study during the study. Exclusion Criteria: * Non-consent of participant * Above 64 or below 45 years of age * Vision not 20/20 or corrected * Food allergies or intolerances * Pregnant, lactating, or have given birth in the past 12 months * Smoke, use tobacco, or abuse drugs * Prior diagnosis of liver or gastrointestinal disease (i.e., primary biliary cirrhosis or gallbladder disease, chronic constipation, diarrhea, Crohn's disease, celiac disease, ulcerative colitis, irritable bowel syndrome, diverticulosis, stomach or duodenal ulcers), hepatitis, HIV, or cancer * Currently taking oral hypoglycemic agents or insulin * History of malabsorptive or bariatric surgery * Cognitively impaired and/or prior diagnosis of neurological disease (i.e., mild cognitive impairment, Alzheimer's disease, vascular dementia, and/or Asperger's syndrome) * Unable to consume the study meals * Concurrent enrollment in another dietary, exercise, or medication study
Where it's running
-
University of Illinois at Urbana-Champaign
Urbana, Illinois, United States Recruiting
Study contacts
- Principal investigator: Naiman Khan, PhD — University of Illinois Urbana-Champaign
- Study coordinator: Naiman Khan, PhD
- Email: nakhan2@illinois.edu
- Phone: 2173001667
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Home-based nutrition intervention for Latinx families with preschool children
This study is testing a home-based nutrition program to see if it can help low-income Latinx families with preschool children eat healthier.
-
Early Cognitive Interventions in Digital Format for Cancer Survivors: Home-Based Training for CRCI
Two digital cognitive training programs done at home (one computerized, one virtual reality) are tested to see if they help adults with cancer-related cognitive changes more than usual care.
-
Healthy Options At Pantries prompts healthier online pantry choices
A digital nudge called HOAP is tested in online food pantries to see if it helps shoppers pick healthier items.
-
Early cognitive changes after same-day hip or knee replacement
This study tests whether older adults (65 or older, 70 per description) who have same-day discharge after hip or knee replacement show changes in cognitive test performance from before surgery to the first day after surgery.
-
Bioavailability of broccoli extract supplements in healthy adults
This study tests how much glucoraphanin and sulforaphane from three broccoli extract versions are absorbed and excreted in healthy adults aged 18–60.
-
Integrated Data for Healthy Aging in Taiwan
This project tests whether combining clinical data, genomics, and microbiome information can help identify early aging-related risks in adults 40 and older in Taiwan.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.